This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2025
20-22 May, 2025Steigenberger Wiltcher's, Brussels
Register Interest for 2025
Menu
2025
Key Sessions
Guillaume Byk
KEYNOTE PANEL Is your Data at Risk? Legal Implications of European Health Data Space
EU Commission
Isabella Fabbri
DUAL DIALOGUE How to Draft a Good Licencing Agreement
PTC Therapeutics, Inc.
Tinne Gilles
DUAL DIALOGUE Success Factors for Licensing Life Science Deals
CSL Vifor
Kathryn Robinson
DUAL DIALOGUE How to Manage AI in Commercial Deals
Isomorphic Labs
keyboard_arrow_right

Day 3 - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Day 3 - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 2 of 2 Streams
08:20 - 08:50
Registration
08:50 - 09:00
Opening Remarks from Chair
09:00 - 10:00
KEYNOTE PANEL Is your Data at Risk? Legal Implications of European Health Data Space
  • Guillaume Byk - Legislative Officer, DG SANTE, EU Commission
  • Chris Foreman - Chief Privacy Officer, Merck Sharp & Dohme
  • Kristof Van Quathem - Partner, Covington & Burling
10:00 - 10:40
DUAL DIALOGUE Round-up on Key Data Privacy Concerns and Conflicts for the Pharmaceutical Industry
  • Florian Zabel - Chief Privacy Officer Roche Group, F. Hoffmann-La Roche Ltd
  • Cristiana Spontoni - Partner, Jones Day
10:40 - 11:10
Networking Break
11:10 - 11:50
DUAL DIALOGUE New Developments in the Regulation, Conduct and Use of Real-World Evidence/Data
  • Arianna Greco - SVP, General Counsel Commercial, Alnylam Pharmaceuticals
  • Lincoln Tsang - Partner, Ropes & Gray
11:50 - 12:30
TRI DIALOGUE Utilising and Managing the Risk of Generative Artificial Intelligence in Day-to-Day Pharma Activities
  • Alejandro Bes - Head Legal - Engagement, Platforms and Data, Novartis
  • Florence Bakri-Lerer - Senior Legal Counsel, Merck
  • Vincent Rezzouk-Hammachi - Partner, Bird & Bird
12:30 - 13:50
Networking Lunch
13:50 - 14:30
DUAL DIALOGUE Key Developments for Advertising and Promotional Materials
  • Antje-Katrin Weigelt - General Counsel, Teva
  • Elizabeth Anne Wright - Partner, Cooley
14:30 - 15:10
DUAL DIALOGUE Compliance Challenges when Supporting Healthcare Systems: Disease Awareness Campaigns, Patient Support Programmes and Healthcare Service Delivery
  • Sabrina Ballet - Vice President, International Legal and Compliance, Blueprint Medicines
  • Marie Manley - Partner, Sidley Austin
15:10 - 15:40
Networking Break
15:40 - 16:20
DUAL DIALOGUE Corporate Disclosure Frameworks for Environmental, Social, and Governance (ESG)
  • Philipp Kohlhaas - Senior Legal Counsel ESG, Boehringer Ingelheim
  • Peter Sellar - Partner, Fieldfisher
16:20 - 17:00
DUAL DIALOGUE Revisions in Whistleblowing, Anti-Bribery, Anti-Corruption Law and Enforcement
  • Cristina Alexandrescu - Assistant General Counsel, GSK Biologicals
  • Annabelle Bruyndonckx - Partner, Simmons & Simmons
17:00 - 17:05
Close of Conference
08:20 - 08:50
Registration
08:50 - 09:00
Opening Remarks from Chair
  • Laetitia Szaller - General Counsel & Head of Compliance, Egetis Therapeutics AB
09:00 - 09:40
Transaction Trends and Deal Landscape in the Life Sciences Sector
  • Sally Shorthose - Partner, Bird & Bird
09:40 - 10:10
Regulatory Scrutiny on Deals: Update on Foreign Direct Investment Screening
  • Orion Berg - Partner, White & Case
10:10 - 10:40
Networking Break
10:40 - 11:20
DUAL DIALOGUE Advice on Key Antitrust Hurdles Impacting Commercial Transactions
  • Niels van Nuland - International Competition Law Counsel, Senior Director Legal, Gilead
  • Marion Provost - National Partner, Dechert
11:20 - 12:00
DUAL DIALOGUE How to Draft a Good Licencing Agreement
  • Isabella Fabbri - Senior Counsel Legal EMEA & Asia Pacific, PTC Therapeutics, Inc.
  • Tom Wilson - Senior Associate, Arnold & Porter
12:00 - 13:30
Networking Lunch
13:30 - 14:10
DUAL DIALOGUE Success Factors for Licensing Life Science Deals
  • Tinne Gilles - General Counsel | Life Science Expert, CSL Vifor
  • Andres Liivak - Partner, White & Case
14:10 - 14:50
DUAL DIALOGUE Key Aspects of IP and How to Avoid Litigation in Deals
  • Alexandra Pygall - Partner, Stephenson Harwood
  • Laetitia Szaller - General Counsel & Head of Compliance, Egetis Therapeutics AB
14:50 - 15:30
DUAL DIALOGUE How to Manage AI in Commercial Deals
  • Kathryn Robinson - Senior Legal Counsel, Isomorphic Labs
  • Sarah Hanson - Partner, Co-Head of the CMS Life Sciences & Healthcare Group, CMS
15:30 - 16:00
Networking Break
16:00 - 16:05
Close of Conference
Day 2
Filter
Streams
Formats
Choose Day